Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial
Hida, Toyoaki, MD, Nokihara, Hiroshi, MD, Kondo, Masashi, MD, Kim, Young Hak, MD, Azuma, Koichi, MD, Seto, Takashi, MD, Takiguchi, Yuichi, Prof, Nishio, Makoto, MD, Yoshioka, Hiroshige, MD, Imamura, Fumio, MD, Hotta, Katsuyuki, Prof, Watanabe, Satoshi, MD, Goto, Koichi, MD, Satouchi, Miyako, MD, Kozuki, Toshiyuki, MD, Shukuya, Takehito, MD, Nakagawa, Kazuhiko, Prof, Mitsudomi, Tetsuya, Prof, Yamamoto, Nobuyuki, Prof, Asakawa, Takashi, PhD, Asabe, Ryoichi, MS, Tanaka, Tomohiro, MS, Tamura, Tomohide, Dr
Published in The Lancet (British edition) (01.07.2017)
Published in The Lancet (British edition) (01.07.2017)
Get full text
Journal Article
Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial
Takahashi, Toshiaki, MD, Yamanaka, Takeharu, Prof, Seto, Takashi, MD, Harada, Hideyuki, MD, Nokihara, Hiroshi, MD, Saka, Hideo, MD, Nishio, Makoto, MD, Kaneda, Hiroyasu, MD, Takayama, Koichi, MD, Ishimoto, Osamu, MD, Takeda, Koji, MD, Yoshioka, Hiroshige, MD, Tachihara, Motoko, MD, Sakai, Hiroshi, MD, Goto, Koichi, MD, Yamamoto, Nobuyuki, Prof
Published in The lancet oncology (01.05.2017)
Published in The lancet oncology (01.05.2017)
Get full text
Journal Article
Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study
Seto, Takashi, MD, Kato, Terufumi, MD, Nishio, Makoto, MD, Goto, Koichi, MD, Atagi, Shinji, MD, Hosomi, Yukio, MD, Yamamoto, Noboru, MD, Hida, Toyoaki, MD, Maemondo, Makoto, MD, Nakagawa, Kazuhiko, Prof, Nagase, Seisuke, MD, Okamoto, Isamu, MD, Yamanaka, Takeharu, PhD, Tajima, Kosei, MSc, Harada, Ryosuke, BS, Fukuoka, Masahiro, MD, Yamamoto, Nobuyuki, Prof
Published in The lancet oncology (01.10.2014)
Published in The lancet oncology (01.10.2014)
Get full text
Journal Article
Single-arm, multicentre, phase II trial of nivolumab for unresectable or recurrent thymic carcinoma: PRIMER study
Katsuya, Yuki, Horinouchi, Hidehito, Seto, Takashi, Umemura, Shigeki, Hosomi, Yukio, Satouchi, Miyako, Nishio, Makoto, Kozuki, Toshiyuki, Hida, Toyoaki, Sukigara, Tamie, Nakamura, Kenichi, Kuchiba, Aya, Ohe, Yuichiro
Published in European journal of cancer (1990) (01.05.2019)
Published in European journal of cancer (1990) (01.05.2019)
Get full text
Journal Article
Randomized Phase III Study of Pemetrexed Plus Cisplatin Versus Vinorelbine Plus Cisplatin for Completely Resected Stage II to IIIA Nonsquamous Non-Small-Cell Lung Cancer
Kenmotsu, Hirotsugu, Yamamoto, Nobuyuki, Yamanaka, Takeharu, Yoshiya, Katsuo, Takahashi, Toshiaki, Ueno, Tsuyoshi, Goto, Koichi, Daga, Haruko, Ikeda, Norihiko, Sugio, Kenji, Seto, Takashi, Toyooka, Shinichi, Date, Hiroshi, Mitsudomi, Tetsuya, Okamoto, Isamu, Yokoi, Kohei, Saka, Hideo, Okamoto, Hiroaki, Takiguchi, Yuichi, Tsuboi, Masahiro
Published in Journal of clinical oncology (01.07.2020)
Published in Journal of clinical oncology (01.07.2020)
Get full text
Journal Article
Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer
Nakagawa, Kazuhiko, Hida, Toyoaki, Nokihara, Hiroshi, Morise, Masahiro, Azuma, Koichi, Kim, Young Hak, Seto, Takashi, Takiguchi, Yuichi, Nishio, Makoto, Yoshioka, Hiroshige, Kumagai, Toru, Hotta, Katsuyuki, Watanabe, Satoshi, Goto, Koichi, Satouchi, Miyako, Kozuki, Toshiyuki, Koyama, Ryo, Mitsudomi, Tetsuya, Yamamoto, Nobuyuki, Asakawa, Takashi, Hayashi, Morihiko, Hasegawa, Wakako, Tamura, Tomohide
Published in Lung cancer (Amsterdam, Netherlands) (01.01.2020)
Published in Lung cancer (Amsterdam, Netherlands) (01.01.2020)
Get full text
Journal Article
CH5424802 (RO5424802) for patients with ALK -rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1–2 study
Seto, Takashi, MD, Kiura, Katsuyuki, Prof, Nishio, Makoto, MD, Nakagawa, Kazuhiko, Prof, Maemondo, Makoto, MD, Inoue, Akira, MD, Hida, Toyoaki, MD, Yamamoto, Nobuyuki, MD, Yoshioka, Hiroshige, MD, Harada, Masao, MD, Ohe, Yuichiro, MD, Nogami, Naoyuki, MD, Takeuchi, Kengo, MD, Shimada, Tadashi, MS, Tanaka, Tomohiro, MS, Tamura, Tomohide, Dr
Published in The lancet oncology (01.06.2013)
Published in The lancet oncology (01.06.2013)
Get full text
Journal Article
Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non‐small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX‐Lung 3
Kato, Terufumi, Yoshioka, Hiroshige, Okamoto, Isamu, Yokoyama, Akira, Hida, Toyoaki, Seto, Takashi, Kiura, Katsuyuki, Massey, Dan, Seki, Yoko, Yamamoto, Nobuyuki
Published in Cancer science (01.09.2015)
Published in Cancer science (01.09.2015)
Get full text
Journal Article
Spotlight on lorlatinib and its potential in the treatment of NSCLC: the evidence to date
Akamine, Takaki, Toyokawa, Gouji, Tagawa, Tetsuzo, Seto, Takashi
Published in OncoTargets and therapy (01.01.2018)
Published in OncoTargets and therapy (01.01.2018)
Get full text
Journal Article
Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial
Yoh, Kiyotaka, Seto, Takashi, Satouchi, Miyako, Nishio, Makoto, Yamamoto, Noboru, Murakami, Haruyasu, Nogami, Naoyuki, Matsumoto, Shingo, Kohno, Takashi, Tsuta, Koji, Tsuchihara, Katsuya, Ishii, Genichiro, Nomura, Shogo, Sato, Akihiro, Ohtsu, Atsushi, Ohe, Yuichiro, Goto, Koichi
Published in The lancet respiratory medicine (01.01.2017)
Published in The lancet respiratory medicine (01.01.2017)
Get more information
Journal Article
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
Mitsudomi, Tetsuya, Dr, Morita, Satoshi, Prof, Yatabe, Yasushi, MD, Negoro, Shunichi, MD, Okamoto, Isamu, MD, Tsurutani, Junji, MD, Seto, Takashi, MD, Satouchi, Miyako, MD, Tada, Hirohito, MD, Hirashima, Tomonori, MD, Asami, Kazuhiro, MD, Katakami, Nobuyuki, MD, Takada, Minoru, Prof, Yoshioka, Hiroshige, MD, Shibata, Kazuhiko, MD, Kudoh, Shinzoh, MD, Shimizu, Eiji, Prof, Saito, Hiroshi, MD, Toyooka, Shinichi, MD, Nakagawa, Kazuhiko, Prof, Fukuoka, Masahiro, Prof
Published in The lancet oncology (01.02.2010)
Published in The lancet oncology (01.02.2010)
Get full text
Journal Article
The Role of Radiotherapy in the Treatment of Small-Cell Lung Cancer
Get full text
Journal Article
Book Review
Plerixafor stem cell mobilization in Japanese children: A post‐marketing study
Goto, Hiroaki, Kanamori, Rie, Nishina, Satoshi, Seto, Takashi
Published in Pediatrics international (01.01.2022)
Published in Pediatrics international (01.01.2022)
Get full text
Journal Article
Real world treatment and outcomes in EGFR mutation-positive non-small cell lung cancer: Long-term follow-up of a large patient cohort
Okamoto, Isamu, Morita, Satoshi, Tashiro, Naoki, Imamura, Fumio, Inoue, Akira, Seto, Takashi, Yamamoto, Nobuyuki, Ohe, Yuichiro, Nakagawa, Kazuhiko, Fukuoka, Masahiro
Published in Lung cancer (Amsterdam, Netherlands) (01.03.2018)
Published in Lung cancer (Amsterdam, Netherlands) (01.03.2018)
Get full text
Journal Article
Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG0605): a multicentre, open-label, randomised phase 3 trial
Goto, Koichi, Dr, Ohe, Yuichiro, MD, Shibata, Taro, MSc, Seto, Takashi, MD, Takahashi, Toshiaki, MD, Nakagawa, Kazuhiko, Prof, Tanaka, Hiroshi, MD, Takeda, Koji, MD, Nishio, Makoto, MD, Mori, Kiyoshi, MD, Satouchi, Miyako, MD, Hida, Toyoaki, MD, Yoshimura, Naruo, MD, Kozuki, Toshiyuki, MD, Imamura, Fumio, MD, Kiura, Katsuyuki, Prof, Okamoto, Hiroaki, MD, Sawa, Toshiyuki, MD, Tamura, Tomohide, MD
Published in The lancet oncology (01.08.2016)
Published in The lancet oncology (01.08.2016)
Get full text
Journal Article
Phase II study of ceritinib in alectinib‐pretreated patients with anaplastic lymphoma kinase‐rearranged metastatic non‐small‐cell lung cancer in Japan: ASCEND‐9
Hida, Toyoaki, Seto, Takashi, Horinouchi, Hidehito, Maemondo, Makoto, Takeda, Masayuki, Hotta, Katsuyuki, Hirai, Fumihiko, Kim, Young Hak, Matsumoto, Shingo, Ito, Masayuki, Ayukawa, Koichi, Tokushige, Kota, Yonemura, Masataka, Mitsudomi, Testuya, Nishio, Makoto
Published in Cancer science (01.09.2018)
Published in Cancer science (01.09.2018)
Get full text
Journal Article
Capmatinib in Japanese patients with MET exon 14 skipping–mutated or MET‐amplified advanced NSCLC: GEOMETRY mono‐1 study
Seto, Takashi, Ohashi, Kadoaki, Sugawara, Shunichi, Nishio, Makoto, Takeda, Masayuki, Aoe, Keisuke, Moizumi, Sanae, Nomura, Satoshi, Tajima, Takeshi, Hida, Toyoaki
Published in Cancer science (01.04.2021)
Published in Cancer science (01.04.2021)
Get full text
Journal Article
Co-expression of IDO1 and PD-L1 in lung squamous cell carcinoma: Potential targets of novel combination therapy
Takada, Kazuki, Kohashi, Kenichi, Shimokawa, Mototsugu, Haro, Akira, Osoegawa, Atsushi, Tagawa, Tetsuzo, Seto, Takashi, Oda, Yoshinao, Maehara, Yoshihiko
Published in Lung cancer (Amsterdam, Netherlands) (01.02.2019)
Published in Lung cancer (Amsterdam, Netherlands) (01.02.2019)
Get full text
Journal Article
Identification of the Best Prognostic Marker Among Immunonutritional Parameters Using Serum C-Reactive Protein and Albumin in Non-Small Cell Lung Cancer
Matsubara, Taichi, Takamori, Shinkichi, Haratake, Naoki, Fujishita, Takatoshi, Toyozawa, Ryo, Ito, Kensaku, Shimokawa, Mototsugu, Yamaguchi, Masafumi, Seto, Takashi, Okamoto, Tatsuro
Published in Annals of surgical oncology (01.06.2021)
Published in Annals of surgical oncology (01.06.2021)
Get full text
Journal Article